Search Within

Maximilian Stahl

Formats
  1. Review (13)
  2. Meeting Abstract (11)
  3. Journal Article (9)
  4. Editorial (5)
  5. Research Letter (3)
  6. Correspondence (1)
Groups
  1. Hematology-Oncology Fellows (42)
  2. Center for Hematologic Malignancies (34)
  3. Department of Medicine (34)
  4. Hematologic Malignancies, Division of (34)
  5. Adult Leukemia (30)
  6. Weinberg Fellows (20)

More Groups

People
  1. Martin Tallman (22)
  2. Aaron Goldberg (18)
  3. Christopher Famulare (10)
  4. Andriy Derkach (9)
  5. Omar Abdel-Wahab (8)
  6. Eytan Stein (7)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (3)
  5. 2021 (11)
  6. 2020 (14)

More Years

Publications
  1. Blood (11)
  2. Leukemia and Lymphoma (7)
  3. American Journal of Hematology (3)
  4. British Journal of Haematology (2)
  5. Expert Review of Hematology (2)
  6. Haematologica (2)

More Publications

Publishers
  1. American Society of Hematology (12)
  2. Taylor & Francis Group (10)
  3. John Wiley & Sons (3)
  4. Nature Publishing Group (3)
  5. Elsevier Inc. (2)
  6. Ferrata Storti Foundation (2)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Venetoclax–azacitidine versus azacitidine for the treatment of primary refractory or first relapsed acute myeloid leukemia. An IPC-DATAML-MSKCC retrospective study
    Correspondence

    Petit, C.; Higue, J.; Acheaibi, Z.; Gilhodes, J.; Hospital, M. A.; Devillier, R.; Bewersdorf, J.; Goldberg, A. D.; Pigneux, A.; Vey, N.; more...
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Altered RNA splicing and AML therapy resistance
    Meeting Abstract

    Wang, E.; Pineda, J.; Kim, W.; Chen, S.; Bourcier, J.; Stahl, M.; Hogg, S.; Knorr, K.; Stanley, R.; Bradley, R.; more...
    Cancer Science (2024)

    Fulltext@MSK | Save
  • Mapping genotypes to chromatin accessibility profiles in single cells
    Journal Article

    Izzo, F.; Myers, R. M.; Ganesan, S.; Mekerishvili, L.; Kottapalli, S.; Prieto, T.; Eton, E. O.; Botella, T.; Dunbar, A. J.; Bowman, R. L.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia
    Research Letter

    Przespolewski, A.; Goldberg, A. D.; Talati, C.; Fazal, S.; Vachhani, P.; Sanikommu, S. R.; Thota, S.; Waksal, J.; Ball, B.; Famulare, C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Racial disparities in patients with TP53 mutated acute myeloid leukemia
    Meeting Abstract

    Badar, T.; Litzow, M. R.; Shallis, R.; Stahl, M.; Bewersdorf, J. P.; Saliba, A. N.; de Camargo Correia, G. S.; Patel, A. A.; Abaza, Y.; Murthy, G. S. G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells
    Journal Article

    North, K.; Benbarche, S.; Liu, B.; Pangallo, J.; Chen, S.; Stahl, M.; Bewersdorf, J. P.; Stanley, R. F.; Erickson, C.; Cho, H.; more...
    Nature Biotechnology (2022)

    Fulltext@MSK | Save
  • Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms
    Research Letter

    King, A. C.; Weis, T. M.; Derkach, A.; Ball, S.; Pandey, M.; Mauro, M. J.; Goldberg, A. D.; Stahl, M.; Famulare, C.; Tallman, M. S.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • Modulation of RNA splicing enhances response to BCL2 inhibition in acute myeloid leukemia
    Meeting Abstract

    Wang, E.; Pineda, J. M. B.; Bourcier, J.; Stahl, M.; Penson, A. V.; Wakiro, I.; Singer, M. E.; Cui, D.; Erickson, C.; Knorr, K.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Comparing outcomes between liposomal daunorubicin/cytarabine (CPX-351) and HMA+venetoclax as frontline therapy in acute myeloid leukemia
    Meeting Abstract

    Grenet, J.; Jain, A. G.; Burkart, M.; Waksal, J.; Famulare, C.; Numan, Y.; Stahl, M.; Mckinnell, Z.; Ball, B.; Ma, X.; more...
    Blood (2021)

    Fulltext@MSK | Save